Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI)
Clinical trial NCT00508924 · COMPLETED
Trial details
- NCT number
- NCT00508924
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.